Form 4: Sarepta Therapeutics Director M. Kathleen Behrens Reports Charitable Gift of Shares
SEC Form 4 Filing
Director M. Kathleen Behrens reports a charitable gift of 746 shares of Sarepta Therapeutics common stock.
Summary
- On September 4, 2024, M. Kathleen Behrens, a director of Sarepta Therapeutics, Inc., reported a transaction involving the company's common stock.
- The transaction was a charitable gift of 746 shares.
- Following the transaction, Behrens directly owns 191,093 shares of Sarepta Therapeutics common stock.
- Behrens also indirectly owns 10,000 shares through a trust.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing regarding a stock transaction. It doesn't convey any strong positive or negative sentiment about the company's performance or future prospects.
Industry Context
This filing is a routine disclosure of a transaction by a company insider and doesn't necessarily reflect a change in the company's overall prospects or performance.
Stakeholder Impact
- The charitable donation has a negligible impact on stakeholders.
Key Dates
| Date | Description |
|---|---|
| 09/04/2024 | Date of the charitable gift transaction |
| 09/05/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.